What you need to know before you call someone "Toxic"
Do you deflect blame or justify your mistakes? Accountability isn't about perfection, it's about owning your impact. If you often say things like 'Sorry you feel that way' or 'I wouldn't have done that if you hadn't…,' you might be dodging responsibility. If vulnerability was punished in your past, defensiveness may feel like self-protection.
Try to shift:
Replace blame with honest reflection.
Shift from 'Why is this happening to me?' to 'What can I do next?'
Do you correct, critique, or offer 'honest feedback' that no one asked for? There's a fine line between being real and being rude. If you regularly highlight flaws without balancing encouragement, it could be toxic. We often judge others where we feel most insecure ourselves.
Try to shift:
Offer the compassion you wish you'd received
Swap unsolicited advice for active listening.
Do you sulk, withdraw, or guilt-trip when disappointed? Manipulation isn't always calculated. Sometimes, it's a learned way to cope when direct communication seems unsafe. If expressing needs was ignored or punished, guilt might feel like the only option.Yet, no matter the underlying reason, yielding power over someone else isn't healthy.
Try to shift:
Practice stating your needs clearly. Map them out by yourself first.
Know that you're allowed to want things, and to ask directly.
Do you take 'no' personally? Are you often trying to change people's minds? Respecting boundaries is a critical relationship skill. If you find yourself pushing back when others set limits, it may be time to pause. If boundaries weren't modeled in childhood, they may feel like rejection now.
Try to shift:
Learn to recognize boundaries as safety that protects you and others too.
Reflect on your own boundaries.
Practice asking people to share their boundaries in times you are unclear.
Do people feel uplifted or drained after being around you? Honest venting can be okay at times, but if you're often stuck in complaint mode, it can impact those around you. What examples do you have of raising the vibe and how does that compare to dampening the energy? Negativity can feel protective, like bracing for impact, but it also can inhibit connection.
Try to shift:
Notice and name small wins and joys.
Ground your honesty in hope.
Do you plan everything, lead everything, and struggle to let go? Control can feel like safety when you've experienced chaos or betrayal. Fear of abandonment and the unknown often fuel control. While these are understandable anxieties, without working on them the need for control can eave others feeling suffocated.
Try to shift:
Create a safe space to explore your fears of letting go
Focus on building inner safety.
Trust what's meant for you won't require force to stay.
Do you ghost, shut down emotionally, or quietly build resentment? Sometimes toxicity is in what we don't do. Silence, avoidance, and passive withdrawal are all signs of disconnection. Avoidance often stems from fear of confrontation or not feeling safe to express emotion.
Try this:
Reflect on the difference between acceptance and avoidance
Start small, you don't have to tackle your biggest problems first.
Maybe you're wondering, 'Does this mean I'm toxic?' Not necessarily. Truth be told, if your toxicity was sky-high you likely wouldn't have made it this far into this article. If you did notice room for growth, excellent work! It's that awareness, that we often overlook, that sparks impactful change. Before you go please remember, no one is perfect, and being willing to look at the truth is meaningful work.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
How I'm Learning to Outlive My Mother
Whenever I miss my mom, I reach for my favorite photo of me and her. We're sitting on the steps in front of my childhood home in Massachusetts, cuddled up next to each other. I'm three years old and proudly wearing blue clip-on earrings to match my white puff-sleeve dress. My mother is flashing a smile that takes up so much space, it's sometimes all I can see. Happy photos like this one, which is protected in a heart-shaped frame, decorate the shelves in my home office. The sadder ones — taken after my mother was diagnosed with metastatic breast cancer — hide inside my desk drawers. They're out of sight, but the truth is, they're always on display in my mind. They sit alongside the many journals in which my mother kept track of my childhood accomplishments and made predictions about my future. 'Mallary's going to go places with her writing,' she wrote in one of them, believing I would one day become an author. 'I'm so proud of her.' My mom passed away from cancer when I was 11, before she could see me graduate middle school, let alone go off to college, pursue a writing career, get married, and have kids. She was just 40 years old when she died — the same age I am now. As I begin to outlive my mother, I've been pondering questions that lack easy answers: How do I venture into this next phase of life that she never got to experience? What are the lessons she taught me (and didn't get to teach) that I want to pass on to my own children? And how can I continue to keep my mom's memory alive? On my 40th birthday, I told my 7-year-old son and 9-year-old daughter why this particular birthday was so significant. They've heard me share stories about my mother for years, but this was the first time they learned how old she'd been when she passed away. 'Just because your mom died when you were 40 doesn't mean you're going to, right, Mommy?' my daughter asked, making my heart sink. 'Oh no honey, I'm not going to die at 40,' I reassured her. 'My mother was sick, but I'm not. I hope to be around for a loooong time.' My words were tightly woven together by years of convincing myself that I won't die young. And yet I know the unpredictability of life could unravel these words at any point, rendering them a lie in my children's minds. I hope my words remain true, but the reality of mortality seems to loom larger now that I'm 40. In some ways it's a relief to have outlived my mother, because it feels like a sign that my fate will not follow hers. But I also find myself wondering: How much longer do I really have? Grief expert Hope Edelman once told me that when you begin to outlive your deceased parent, you are 'crossing the silent threshold.' When experiencing this rite of passage, she said, it's normal to grow fearful about dying and/or to experience mourning anew. Edelman recommends honoring the silent threshold by naming it and recognizing what surfaces. If growing up meant living without my mother, then I wanted to stay in the past forever. I've been recognizing it by going through the photos in my desk drawers and exposing the hard truths behind them. There's one in particular that I keep returning to — a picture of me looking happy as can be just five days after my mother's death. I was at my first-ever middle school dance, smiling and looking perfectly poised, like a ballerina about to do a pirouette. I thought I was supposed to be 'strong' and 'resilient,' so I tried pretending to be okay. But behind that happy facade was a little girl who felt like her whole world had fallen apart. If growing up meant living without my mother, then I wanted to stay in the past forever. I remember doing the math as I got ready for the dance, counting out exactly how many hours and minutes had passed since my mother died; they say time heals, but I learned at a young age that time also hurts. Every birthday, holiday, and missed milestone became a painful reminder of the permanence of my mother's absence. When you lose a parent at a young age, you're always playing a game of catch-up that reminds you of not just who you've lost but what you've lost — all those life lessons that you hope your mom would have shared to help you navigate the world. Having lost my mother just before my teenage years, I found it especially difficult to navigate puberty without her. I wanted her to teach me everything I thought a teenage girl was supposed to learn: how to use an eyelash curler, shop for bras, insert a tampon, and shave my legs. I feel a pang whenever I look at one close-up photo of me as a 14-year-old, with eyelashes that were clumped together by far too much Maybelline mascara. I had taught myself how to apply it, hoping that it would help me look more like my mom, who had always worn it until she got too sick and weak to put it on. But it wasn't until age 38 that I learned how to properly use an eyelash curler. I had always applied my mascara and then curled my lashes, until one day a friend told me I was supposed to do it the other way around. How did I not know that? I thought to myself, feeling the load of loss grow heavier. Soon enough, when my lip-gloss-loving daughter expresses interest in makeup, I will show her how the curler works. Until then, I'm trying to teach my kids the bigger life lessons that my mom shared with me when I was young: how to persevere in the face of uncertainty, work hard for what you want, and show familial love. Lately I've felt a greater sense of urgency around sharing these lessons, especially when I think about what else is hiding in my desk drawers: genetic test results showing that, as my mother's daughter, I'm at a higher risk of developing breast cancer compared to other women my age. As I enter midlife, it saddens me to know that my mom never got to witness all the places I've gone with my writing — and that she won't get to celebrate alongside me when my debut memoir is published this summer. But I find comfort in knowing that she was there from the very start, believing in me and giving me reason to feel hopeful about the future. Mallary Tenore Tarpley is a journalism professor at the University of Texas at Austin and author of the memoir SLIP. The post How I'm Learning to Outlive My Mother appeared first on Katie Couric Media. Solve the daily Crossword
Yahoo
14 minutes ago
- Yahoo
Life sciences VC Omega Funds closes $647m funding round
Life sciences venture capital (VC) company Omega Funds has closed its eighth fund, with capital commitments totalling $647m. As with its previous funds, the US-based business said its oversubscribed funding, which had initially targeted a $600m close, will continue executing on its strategy to support management teams in the US and Europe that target severe, unmet medical needs through company creation, early venture rounds, and later-stage financing. Omega Funds managing director Francesco Draetta said: 'We believe our broad investment strategy is well-positioned for navigating this period of macro and policy uncertainty. 'We look forward to contributing our capital, expertise, and network connectivity in partnering with entrepreneurs, founders, co-investors, and the broader community to transform the standards of care for severe diseases.' According to Omega, it has raised $2.5bn since its first fund in 2004 to support the development of medical devices and therapeutics across indications including oncology, immunology, and rare diseases. In total, 52 products have been brought to market by Omega's former portfolio companies, with the VC's previous investments resulting in 50 exits via M&A, and 47 public listings. M&A exits include SoniVie, Scorpion Therapeutics, and Amunix Pharmaceuticals, which were acquired by Boston Scientific, Eli Lilly, and Sanofi, respectively. Companies that Omega has invested in have gone on to launch initial public offerings (IPO). These include Kestra Medical Technologies, Beta Bionics, and Imago Biosciences, all of which are listed on the Nasdaq exchange. Omega Funds' founder and managing director Otello Stampacchia commented: 'By exceeding its target size, fund VIII is a recognition of our investment strategy and track record of consistent exits across market cycles.' Life science companies are typically reliant on investment from VC or private equity (PE) businesses. While research by Bain & Company found that deal value in 2023 struggled to match the pace of previous years, more recent research by the consultant found that healthcare PE soared to an estimated $115bn in 2024, making it the second-highest deal value total on record. Other significant entities backing life science companies include Symbiotic Capital. The credit company from biotech entrepreneur Arie Belldegrun, founder of Kite Pharma and co-founder of Bellco Capital, launched in August 2024 with $600m for life science-specific loans. "Life sciences VC Omega Funds closes $647m funding round" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Yahoo
Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings
We recently published Elevance Health, Inc. (NYSE:ELV) is one of this week's top performers. Elevance Health fell by 18.66 percent week-on-week to close at $277.09 on Friday versus $340.67 a week earlier following dismal earnings performance in the second quarter of the year. In its earnings release, Elevance Health, Inc. (NYSE:ELV) said net income during the period dropped by 24.2 percent to $1.744 billion from $2.301 billion in the same period last year, pushing its six-month net earnings lower by 13.7 percent to $3.928 billion from $4.55 billion year-on-year. Revenues for the second quarter, however, increased by 13.4 percent to $49.776 billion from $43.886 billion year-on-year, while revenues for the first half of the year grew by 14.1 percent to $98.667 billion from $86.463 billion year-on-year. A medical professional working at a computer, utilizing the company's digital solutions to improve care quality for consumers. Looking ahead, Elevance Health, Inc. (NYSE:ELV) also lowered its guidance amid elevated medical cost trends in Obamacare and slower rate alignment in Medicaid. Given the industry-wide impact of elevated cost trends, the company said it now expects 2025 GAAP net income per diluted share to be approximately $24.10 and adjusted net income per diluted share to be approximately $30. While we acknowledge the potential of ELV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio